Pulmatrix
PULM | NASDAQ
$1.29
$0.00 (0.00%)
At close: Nov 16, 2026, 3:59 PM ET
$1.31
+$0.02 (+1.55%)
After-hours:
Nov 16, 2026, 6:15 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
30.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #785/1021 (Top 77%)
Key Statistics
Market Data
Market Cap $4.71M
1D Range
1.25 1.39
52W Range
1.19 4.75
Valuation (TTM)
PE -1.17
PB 1.84
EV/EBITDA -0.63
Valuation (NTM)
Forward PE 2.62
Forward PEG 0.02
Price Target $0.00
Cash Flow
FCF Yield -83.0%
SBC Adj. FCF Yield -83.3%
SBC Impact -0.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -145.3% |
-32.1%
Dil EPS 3Y | 5Y 44.9% |
40.7%
FCF 3Y | 5Y 56.8% |
31.9%
Returns
ROA -123.6%
ROE -109.3%
ROIC -160.8%
Financial Health
Net Cash
$2.17M
Current Ratio 4.70
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respirat...
Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Mar 21, 2014
Website www.pulmatrix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PULM